Timeline
AstraZeneca and Ionis ATTR-CM trial fails primary endpoint
Health & Bio Today: Creo Medical lifts FY26 guidance after Q1 beat, Verici Dx, Futura Medical, genedrive, AstraZeneca
AstraZeneca's Datroway wins EU approval recommendation for first-line triple-negative breast cancer
Health & Bio Today: AstraZeneca's Truqap wins FDA approval for prostate cancer
The Premarket Brief: Reabold in takeover talks with Union Jack Oil, Frasers Group's Aussie bid, Peel Hunt, AstraZeneca
AstraZeneca's Truqap approved in US as targeted treatment for prostate cancer
Health & Bio Today: CelLBxHealth wins AstraZeneca services deal, Avacta Group, AstraZeneca
AstraZeneca wins US approval for Imfinzi in early high‑risk bladder cancer
Health & Bio Today: ImmuPharma narrows loss with P140 partnership push, Physiomics, ValiRx, AstraZeneca
AstraZeneca says FDA extends decision date for camizestrant, allowing extra data review
Health & Bio Today: Genedrive chairman exits as Nugent joins board, Novo Nordisk, Crism, Diaceutics, CVS Group, AstraZeneca,
The Premarket Brief: Sound Energy sells Tendrara stake for $57m, CVS Group, Arrow Exploration, AstraZeneca, Atalaya Mining
AstraZeneca wins CHMP backing for Enhertu tumour‑agnostic approval
Health & Bio Today: EMV Capital spotlights XF-73 ahead of Phase 3, IXICO, Oxford Nanopore, AstraZeneca
Broker calls AstraZeneca pipeline news “frenetic”, repeats Sell rating
Health & Bio Today: AstraZeneca wins dual FDA approvals, Advanced Medical Solutions, CelLBxHealth, GSK
AstraZeneca secures US approval for blood pressure drug Baxfendy
AstraZeneca's breast cancer drug Enhertu cleared by FDA
AstraZeneca says Imfinzi plus enfortumab vedotin improves survival in muscle‑invasive bladder cancer
AstraZeneca's Truqap recommended by FDA advisory panel for a form of prostate cancer
AstraZeneca fails to win FDA advisory backing for camizestrant
Tech Today: Built Cybernetics, Visum, Weir Group, Sage, ZOO Digital
Health & Bio Today: GSK drops despite strong Q1, SkinBioTherapeutics, Solvonis, AstraZeneca, Ondine Biomedical
Tech Today: Smarter Web, Sage, MedPal AI, Shearwater, ZOO Digital, AstraZeneca, Ondine Biomedical
The Premarket Brief: GSK, Lloyds, AstraZeneca, Prudential, Haleon, Ondine Biomedical, Halfords, Frasers Group, Treatt
AstraZeneca repeats 2026 guidance as Q1 revenue rises 8%
Health & Bio Today: GSK, AstraZeneca, Hemogenyx Pharmaceuticals, Genflow Biosciences
AstraZeneca wins US approval for Breztri in asthma
Health & Bio Today: GSK's efimosfermin wins FDA Breakthrough and EMA PRIME status, PureTech Health, Ondine Biomedical, AstraZeneca
AstraZeneca wins US approval for once-weekly Saphnelo self-injection
AstraZeneca's Ultomiris meets primary endpoint in IgAN Phase III
AstraZeneca reports tozorakimab cuts COPD exacerbations in Phase III MIRANDA
More in Telecoms
French billionaire Xavier Niel takes stake in Vodafone
French billionaire Xavier Niel is investing in Vodafone Group via his Vega entity, with funding provided entirely by Niel personally and financial institutions.